Journal Watch

Open

Advertisement

Journal Watch

1-20 of 2278 results
1 2 3 4 5 Next »

Bempedoic acid and cardiovascular outcomes in statin-intolerant patients

Mar 27, 2023 by
Michael Mahmoudi, MD - S Nissen, et al.; NEJM 2023 Online

Bempedoic acid and cardiovascular outcomes in statin-intolerant patients

Five-year follow-up after transcatheter repair of secondary mitral regurgitation

Mar 27, 2023 by
Michael Mahmoudi, MD - G Stone, et al.; NEJM 2023 Online

Five-year follow-up after transcatheter repair of secondary mitral regurgitation

Transcatheter repair for patients with tricuspid regurgitation

Mar 27, 2023 by
Michael Mahmoudi, MD - P Sorajja, et al.; NEJM 2023 Online

Transcatheter repair for patients with tricuspid regurgitation

Transcatheter edge-to-edge repair in patients with anatomically complex degenerative mitral regurgitation.

Feb 28, 2023 by
Michael Mahmoudi, MD - J Hausleiter, et al.; JACC 2023; 81:431-442

Transcatheter edge-to-edge repair in patients with anatomically complex degenerative mitral regurgitation.

Impact of transcatheter mitral valve repair availability on volume and outcomes of surgical repair.

Feb 28, 2023 by
Michael Mahmoudi, MD - A Lowenstern, et al.; JACC 2023; 81:521-532

Impact of transcatheter mitral valve repair availability on volume and outcomes of surgical repair.

Coronary artery lesion lipid content and plaque burden in diabetic and nondiabetic patients: PROSPECT II

Feb 28, 2023 by
Michael Mahmoudi, MD - C Gyldenkerne, et al.; Circ 2023; 147:469-481

Coronary artery lesion lipid content and plaque burden in diabetic and nondiabetic patients: PROSPECT II

Survival after invasive or conservative management of stable coronary disease

Jan 31, 2023 by
Michael Mahmoudi, MD - J Hochman, et al.; Circ 2023; 147-8-19

Survival after invasive or conservative management of stable coronary disease

Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study

Jan 31, 2023 by
Michael Mahmoudi, MD - J Kang, et al.; Circ 2023; 147:108-117

Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study

Improving risk stratification for patients with type 2 myocardial infarction

Jan 31, 2023 by
Michael Mahmoudi, MD - C Taggart, et al.; JAA 2023; 81:156-168

Improving risk stratification for patients with type 2 myocardial infarction

Survival after septal reduction in patients >65 years old with obstructive hypertrophic cardiomyopathy

Jan 31, 2023 by
Michael Mahmoudi, MD - A Mantias, et al.; JACC 2023; 81:105-115

Survival after septal reduction in patients >65 years old with obstructive hypertrophic cardiomyopathy

Randomized comparison of transcatheter edge-to-edge repair for degenerative mitral regurgitation in prohibitive surgical risk patients.

Dec 28, 2022 by
Michael Mahmoudi, MD - D Lim, et al.; JACC Interv 2022; 15:2523-2536

Randomized comparison of transcatheter edge-to-edge repair for degenerative mitral regurgitation in prohibitive surgical risk patients.

Defibrillation strategies for refractory ventricular fibrillation.

Dec 28, 2022 by
Michael Mahmoudi, MD - S Cheskes, et al.; NEJM 2022; 387:1947-1956

Defibrillation strategies for refractory ventricular fibrillation.

Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation and cardiogenic shock.

Dec 28, 2022 by
Michael Mahmoudi, MD - T Simard, et al.; JACC 2022 80, 2071-2084

Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation and cardiogenic shock.

Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation.

Nov 28, 2022 by
Michael Mahmoudi, MD - T Tanaka, et al.; JACC Cardiovasc Interv 2022; 15:1731-1740

Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation.

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Nov 28, 2022 by
Michael Mahmoudi, MD - Y Li, et al.; Lancet 2022 Online

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling.

Nov 28, 2022 by
Michael Mahmoudi, MD - S Yoon et al.; JACC Cardiovasc Interv 2022; 15:1711-1722

Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling.

Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease.

Nov 28, 2022 by
Michael Mahmoudi, MD - M O’Donoghue, et al.; NEJM 2022; 387:1855-1865

Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease.

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score.

Oct 24, 2022 by
Michael Mahmoudi, MD - N Shah, et al.; JACC Intv 2022; 15:1893-1905

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score.

Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes.

Oct 24, 2022 by
Michael Mahmoudi, MD - J Saw, et al.; JACC 2022; 80:1585-1597

Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes.

Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial.

Oct 24, 2022 by
Michael Mahmoudi, MD - J Lindholt, et al.; NEJM 2022; 387:1385-1394

Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial.

1-20 of 2278 results
1 2 3 4 5 Next »

CRTonline on Facebook

CRTonline on Twitter

Tweets by CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Refine Your Results

Search

Track

Type

Bempedoic acid and cardiovascular outcomes in statin-intolerant patients

Five-year follow-up after transcatheter repair of secondary mitral regurgitation

Transcatheter repair for patients with tricuspid regurgitation

Transcatheter edge-to-edge repair in patients with anatomically complex degenerative mitral regurgitation.

Impact of transcatheter mitral valve repair availability on volume and outcomes of surgical repair.

Coronary artery lesion lipid content and plaque burden in diabetic and nondiabetic patients: PROSPECT II

Survival after invasive or conservative management of stable coronary disease

Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study

Improving risk stratification for patients with type 2 myocardial infarction

Survival after septal reduction in patients >65 years old with obstructive hypertrophic cardiomyopathy

Randomized comparison of transcatheter edge-to-edge repair for degenerative mitral regurgitation in prohibitive surgical risk patients.

Defibrillation strategies for refractory ventricular fibrillation.

Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation and cardiogenic shock.

Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation.

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling.

Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease.

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score.

Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes.

Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial.

Explore the Site

Stay Connected

Journal Watch

Refine Your Results

Search

Track

Type

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected